Please login to the form below
dementia
This page shows the latest dementia news and features for those working in and with pharma, biotech and healthcare.
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
Today, over 55 million people are living with dementia and this is projected to increase to nearly 140 million by 2050.
Latest news
-
Alzheimer’s Association report highlights need to improve patient-physician communication
They also expressed concerns about how patients will be cared for following a dementia diagnosis in light of specialist shortages and few referral options.
-
Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
The decision comes two months after the drug received accelerated approval in the US for patients with mild cognitive impairment or mild dementia stage of disease. ... The study met its primary endpoint, reducing clinical decline by 27% on the global
-
Alzheimer’s Research UK welcomes government’s pledge to tackle dementia crisis
This work combines our key commitments in mental health, cancer, dementia and health disparities into a single, powerful strategy,’ Barclay said in a written ministerial statement. ... as ‘record’ NHS funding to help reduce the COVID-19 backlog of
-
Alzheimer’s Society urges UK government to deliver on dementia plan
By 2025, around one million people are predicted to be living with dementia, increasing to 1.6 million by 2040. ... Research conducted by the charity has also revealed that three in five people affected by dementia have struggled to get social care in
-
Biogen and Eisai’s Alzheimer’s drug receives FDA accelerated approval
Specifically, Leqembi is indicated for patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. ... The study met its primary endpoint and reduced clinical decline by 27
More from news
Approximately 60 fully matching, plus 231 partially matching documents found.
Latest Intelligence
-
Preparing for a new era in Alzheimer’s disease
Dementia is currently the seventh leading cause of death among all diseases and one of the major causes of disability and dependency among older people globally, according to the World Health ... Organization. Diagnosis of Alzheimer’s disease (AD), the
-
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors. ... low wages, and a higher risk of dementia, lower cognitive performance and faster memory decline.
-
The role of digital health technology tools in supporting medical adherence
Illness factors (psychiatric diseases and dementias). Disruption of lifestyle, limited autonomy.
-
Alzheimer’s disease: the search for a cure
There has been limited progress in the development of new treatments for dementia- causing diseases and Alzheimer’s disease and other dementias remain a significant unmet clinical need. ... up subtle clues of disease in people who don’t yet have any
-
Alzheimer’s: the search for a cure
In closing, a 2020 report by the Lancet Commission identified 12 lifestyle-related risk factors for dementia. ... By seeking help and making simple lifestyle changes, we can delay the onset of dementia by 40%, according to the Lancet Commission report.
More from intelligence
Approximately 5 fully matching, plus 24 partially matching documents found.
Latest appointments
-
New hires at EMA, Gilead and BeiGene
Most recently, Grant was chief executive officer of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease.
-
UK Dementia Research Institute names director
He added: “I want the Institute to be the most exciting place in the world for breakthrough dementias research. ... and previously overlooked fields that could contribute towards our understanding of the dementias.
-
NHiS appoints mental health associate director
During this time, he has worked closely with local authorities to publish the Merton Mental Health Needs Assessment and helped to develop the Alzheimer's Society's Dementia Hub.
-
New health ministers and re-appointments after reshuffle
resistance, cancer, dementia, diabetes as well as issues around vaccination and the prevention of long-term conditions.
-
IMI appoints new chair of scientific committee
Prof da Silva Lima described the appointment as a “great honour” and praised the work of the IMI so far, which includes a dementia trials alliance between pharma companies and a
More from appointments
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Putting prevention at the heart of the future of the NHS
No disease area epitomises this reality better than CVD. Poor heart health leads to heart attacks, strokes, chronic kidney disease, peripheral arterial disease and even the onset of vascular dementia.
-
Powering Rapid Cognitive Analysis with AI
Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.
-
Black community representation in clinical trials
This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community. Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical
-
The future of dementia and the important role of healthcare communication in raising awareness
Caring for people with dementia on hospital wards. London: Alzheimer's Society; 2009. ... Dementia UK: report to the Alzheimer’s society. London: Alzheimer’s Society; 2014.
-
Lifesaving QR Code Wearable Launched to Help Emergency Services
We all know someone vulnerable, and people with conditions such as diabetes, epilepsy, and dementia could benefit from medical interventions during those critical moments.
More from PMHub
Approximately 6 fully matching, plus 25 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
- Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
- Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To transform lives through communication that changes behaviour and improves health outcomes....
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
